These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 31784984)
1. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma. Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984 [TBL] [Abstract][Full Text] [Related]
2. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells. Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500 [TBL] [Abstract][Full Text] [Related]
3. Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma. Nakazawa T; Morimoto T; Maeoka R; Yamada K; Matsuda R; Nakamura M; Nishimura F; Yamada S; Park YS; Tsujimura T; Nakagawa I Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892084 [TBL] [Abstract][Full Text] [Related]
4. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment. Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051 [TBL] [Abstract][Full Text] [Related]
5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
6. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival. Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437 [TBL] [Abstract][Full Text] [Related]
7. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells. Shaim H; Shanley M; Basar R; Daher M; Gumin J; Zamler DB; Uprety N; Wang F; Huang Y; Gabrusiewicz K; Miao Q; Dou J; Alsuliman A; Kerbauy LN; Acharya S; Mohanty V; Mendt M; Li S; Lu J; Wei J; Fowlkes NW; Gokdemir E; Ensley EL; Kaplan M; Kassab C; Li L; Ozcan G; Banerjee PP; Shen Y; Gilbert AL; Jones CM; Bdiwi M; Nunez-Cortes AK; Liu E; Yu J; Imahashi N; Muniz-Feliciano L; Li Y; Hu J; Draetta G; Marin D; Yu D; Mielke S; Eyrich M; Champlin RE; Chen K; Lang FF; Shpall EJ; Heimberger AB; Rezvani K J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34138753 [TBL] [Abstract][Full Text] [Related]
11. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669 [TBL] [Abstract][Full Text] [Related]
12. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma. Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J Front Immunol; 2020; 11():835. PubMed ID: 32457755 [TBL] [Abstract][Full Text] [Related]
13. CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment. Kong D; Kwon D; Moon B; Kim DH; Kim MJ; Choi J; Kang KS Biomed Pharmacother; 2024 May; 174():116436. PubMed ID: 38508081 [TBL] [Abstract][Full Text] [Related]
14. Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling. Zheng P; Zhang X; Ren D; Bai Q Neurol India; 2024 Mar; 72(2):297-303. PubMed ID: 38691473 [TBL] [Abstract][Full Text] [Related]